Aurora has been serving the global scientific research community since 1990. Headquartered in Vancouver, Canada, the company started manufacturing analytical instrumentation based on a patented capacity coupled plasma emission technology. In 2000, Aurora became the first to develop a non-radioactive, label-free technology for the study and high throughput screening of ion channel and transporter targets. This technology has been rapidly incorporated into many pharmaceutical drug discovery pipelines and academic labs.
Capitalizing on this expertise in high throughput technologies, Aurora expanded its products to include the VERSA series of automated liquid handling platforms aimed at the life science, molecular diagnostics, and precision medicine fields. They are committed to improving the quality of human and environmental health by providing products and services that facilitate higher throughput while enhancing quality, accuracy, and precision.
Visit Aurora's website here